MAPS PBC is pioneering the development of psychedelic medicine. We are building a team of diverse, passionate, and best-in-class professionals – spanning clinical development, regulatory, commercial, medical and more – to help make MDMA-assisted therapy an FDA-approved treatment for PTSD.

Help Build the Future of Psychedelic Medicine

Why Work for MAPS Public Benefit Corporation?

Changing the World

We are a diverse team that shares a deep belief in the critical importance of our work and its potential to change the world.

Prioritizing Public Benefit

We are pioneering a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency.

Advancing Science & Mental Health

We are conducting high-quality scientific research at the cutting edge of mental health. We are committed to open science and regularly publish our findings in leading academic journals.
MAPS PBC is a distributed team that uses technology and periodic in-person gatherings to stay connected. We look for people who are comfortable with and skilled at remote work and collaboration.

MAPS PBC commits to building a supportive, equitable, and accessible workplace. We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, arrest or conviction record, military and veteran status, religions, abilities, and perspectives.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Contact Us
Privacy Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about the MDMA-AT Education Program

You have Successfully Subscribed!